You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Fistula closure and residual incontinence outcomes at discharge and 3 month follow-up, by site

From: Clinical procedures and practices used in the perioperative treatment of female genital fistula during a prospective cohort study

  Site N (%)
  Total (n = 1354) BG 1 (n = 85) BG 2 (n = 50) BG 3 (n = 5) GU (n = 251) NI 1 (n = 74) NI 2 (n = 97) NG 1 (n = 59) NG 2 (n = 210) NG 3 (n = 153) UG 1 (n = 165) UG 2 (n = 205)
Urinary fistula closure at end of repair surgery (n = 1299) 1245 (95.8) 73 (88.0) 45 (93.8) 5 (100.0) 231 (93.9) 63 (95.5) 89 (100) 50 (94.3) 195 (95.1) 141 (94.6) 155 (99.4) 198 (99.5)
Urinary fistula closure at discharge (n = 1307) 1104 (84.5) 62 (75.6) 34 (70.8) 5 (100.0) 204 (82.9) 40 (59.7) 72 (86.8) 39 (72.2) 189 (90.9) 115 (76.5) 141 (88.1) 203 (100.0)
Urinary fistula closure at 3 month follow-up (n = 1274) 1039 (81.6) 52 (73.2) 34 (70.8) 3 (60.0) 185 (75.2) 40 (59.7) 45 (66.2) 37 (69.8) 190 (91.4) 117 (80.1) 138 (86.8) 198 (97.5)
Residual incontinence at discharge among women with urinary fistula (n = 1084) 219 (20.2) 19 (32.8) 9 (27.3) 2 (66.7) 28 (13.7) 3 (7.9) 17 (24.3) 12 (31.6) 21 (11.2) 35 (31.0) 26 (18.6) 47 23.62
Residual incontinence at 3 months follow-up among women with urinary fistula (n = 1015) 192 (18.9) 9 (19.2) 16 (47.1) 3 (100.0) 23 (12.5) 4 (10.5) 18 (40.9) 8 (21.6) 18 (9.8) 34 (29.1) 15 (10.9) 44 (23.3)
RVF Closure at discharge (n = 47) 44 (93.6) 1 (100.0) 2 (100.0) N/A 9 (90.0) 2 (100.0) 4 (100.0) 3 (100.0) 5 (71.4) 6 (100.0) 5 (100.0) 7 (100.0)
RVF Closure at 3 month follow-up (n = 43) 36 (83.7) 1 (100.0) 1 (50.0) N/A 8 (80.0) 3 (100.0) 2 (100.0) 3 (100.0) 3 (75.0) 3 (50.0) 5 (100.0) 7 (100.0)
  1. BG = Bangladesh, GU = Guinea, NI = Niger, NG = Nigeria, UG = Uganda.
  2. N/A = not applicable.